BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang P, Gong Q, Hu J, Li X, Zhang X. Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases. J Med Chem 2021;64:298-325. [PMID: 33356214 DOI: 10.1021/acs.jmedchem.0c01704] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Pu Y, Yin H, Dong C, Xiang H, Wu W, Zhou B, Du D, Chen Y, Xu H. Sono-Controllable and ROS-Sensitive CRISPR-Cas9 Genome Editing for Augmented/Synergistic Ultrasound Tumor Nanotherapy. Adv Mater 2021;33:e2104641. [PMID: 34536041 DOI: 10.1002/adma.202104641] [Reference Citation Analysis]
2 Ye YX, Wu SY, Chen XY, Yu YW, Zeng SM, Wang ZC, Jiao QC, Zhu HL. Glutathione-responsive prodrug conjugates for image-guided combination in cancer therapy. Eur J Med Chem 2021;225:113746. [PMID: 34388382 DOI: 10.1016/j.ejmech.2021.113746] [Reference Citation Analysis]
3 Wang CJ, Guo X, Zhai RQ, Sun C, Xiao G, Chen J, Wei MY, Shao CL, Gu Y. Discovery of penipanoid C-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivatives as potential anticancer agents by inhibiting cell proliferation and inducing apoptosis in hepatocellular carcinoma cells. Eur J Med Chem 2021;224:113671. [PMID: 34237623 DOI: 10.1016/j.ejmech.2021.113671] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Liao X, Yang C, Lin H, Li B. Quenching effects of (-)-Epigallocatechin gallate for singlet oxygen production and its protection against oxidative damage induced by Ce6-mediated photodynamic therapy in vitro. Photodiagnosis Photodyn Ther 2021;36:102467. [PMID: 34333147 DOI: 10.1016/j.pdpdt.2021.102467] [Reference Citation Analysis]
5 Wang J, Sun D, Huang L, Wang S, Jin Y. Targeting Reactive Oxygen Species Capacity of Tumor Cells with Repurposed Drug as an Anticancer Therapy. Oxid Med Cell Longev 2021;2021:8532940. [PMID: 34539975 DOI: 10.1155/2021/8532940] [Reference Citation Analysis]
6 Yi H, Lu W, Liu F, Zhang G, Xie F, Liu W, Wang L, Zhou W, Cheng Z. ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer. J Nanobiotechnology 2021;19:134. [PMID: 33975609 DOI: 10.1186/s12951-021-00877-6] [Reference Citation Analysis]